These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32678592)

  • 1. Mechanistic Insight into Antiretroviral Potency of 2'-Deoxy-2'-β-fluoro-4'-azidocytidine (FNC) with a Long-Lasting Effect on HIV-1 Prevention.
    Sun L; Peng Y; Yu W; Zhang Y; Liang L; Song C; Hou J; Qiao Y; Wang Q; Chen J; Wu M; Zhang D; Li E; Han Z; Zhao Q; Jin X; Zhang B; Huang Z; Chai J; Wang JH; Chang J
    J Med Chem; 2020 Aug; 63(15):8554-8566. PubMed ID: 32678592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal absorption mechanisms of 2'-deoxy-2'-β-fluoro-4'-azidocytidine, a cytidine analog for AIDS treatment, and its interaction with P-glycoprotein, multidrug resistance-associated protein 2 and breast cancer resistance protein.
    Liu Y; Liu B; Zhang Y; Peng Y; Huang C; Wang N; Jiang J; Wang Q; Chang J
    Eur J Pharm Sci; 2017 Jul; 105():150-158. PubMed ID: 28487144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamivudine for the treatment of HIV.
    Kumar PN; Patel P
    Expert Opin Drug Metab Toxicol; 2010 Jan; 6(1):105-14. PubMed ID: 20001611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-human immunodeficiency virus type 1 activity, intracellular metabolism, and pharmacokinetic evaluation of 2'-deoxy-3'-oxa-4'-thiocytidine.
    de Muys JM; Gourdeau H; Nguyen-Ba N; Taylor DL; Ahmed PS; Mansour T; Locas C; Richard N; Wainberg MA; Rando RF
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1835-44. PubMed ID: 10428900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the antiretroviral drug 2'-deoxy-2'-β-fluoro-4'-azidocytidine (FNC) on P-gp, MRP2 and BCRP expressions and functions.
    Liu Y; Wang Y; Peng Y; Liu B; Ma F; Jiang J; Wang Q; Chang J
    Pharmazie; 2018 Sep; 73(9):503-507. PubMed ID: 30223932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a population simulation model for HIV monotherapy virological outcomes using lamivudine.
    Hurwitz SJ; Asif G; Schinazi RF
    Antivir Chem Chemother; 2007; 18(6):329-41. PubMed ID: 18320937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral activity of FNC, 2'-deoxy-2'-β-fluoro-4'-azidocytidine, against human and duck HBV replication.
    Zheng L; Wang Q; Yang X; Guo X; Chen L; Tao L; Dong L; Li Y; An H; Yu X; Wang Q; Chang J
    Antivir Ther; 2012; 17(4):679-87. PubMed ID: 22452880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emtricitabine compared with lamivudine may preserve future therapeutic options in HIV-1-infected children.
    Frange P; Blanche S; Chaix ML
    J Antimicrob Chemother; 2013 Nov; 68(11):2694-5. PubMed ID: 23743089
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantification of 2'-deoxy-2'-β-fluoro-4'-azidocytidine in rat and dog plasma using liquid chromatography-quadrupole time-of-flight and liquid chromatography-triple quadrupole mass spectrometry: Application to bioavailability and pharmacokinetic studies.
    Peng Y; Cheng T; Dong L; Zhang Y; Chen X; Jiang J; Zhang J; Guo X; Guo M; Chang J; Wang Q
    J Pharm Biomed Anal; 2014 Sep; 98():379-86. PubMed ID: 24999865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral and cellular metabolism interactions between Dexelvucitabine and lamivudine.
    Hernandez-Santiago BI; Mathew JS; Rapp KL; Grier JP; Schinazi RF
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2130-5. PubMed ID: 17403996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New drugs--reports of new drugs recently approved by the FDA. Lamivudine.
    Ohta Y; Shinkai I
    Bioorg Med Chem; 1997 Apr; 5(4):639-40. PubMed ID: 9158860
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC].
    Taylor DL; Ahmed PS; Tyms AS; Wood LJ; Kelly LA; Chambers P; Clarke J; Bedard J; Bowlin TL; Rando RF
    Antivir Chem Chemother; 2000 Jul; 11(4):291-301. PubMed ID: 10950391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized study of emtricitabine and lamivudine in stably suppressed patients with HIV.
    Benson CA; van der Horst C; Lamarca A; Haas DW; McDonald CK; Steinhart CR; Rublein J; Quinn JB; Mondou E; Rousseau F;
    AIDS; 2004 Nov; 18(17):2269-76. PubMed ID: 15577539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New drugs.
    Pozniak A
    J HIV Ther; 2008 Jun; 13(2):27-33. PubMed ID: 18953271
    [No Abstract]   [Full Text] [Related]  

  • 15. Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships in HIV-infected persons.
    Fletcher CV; Kawle SP; Kakuda TN; Anderson PL; Weller D; Bushman LR; Brundage RC; Remmel RP
    AIDS; 2000 Sep; 14(14):2137-44. PubMed ID: 11061655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Pyrimidine Analog FNC Potently Inhibits the Replication of Multiple Enteroviruses.
    Xu N; Yang J; Zheng B; Zhang Y; Cao Y; Huan C; Wang S; Chang J; Zhang W
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32075935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reverse transcriptase fidelity and HIV-1 variation.
    Balzarini J; Pelemans H; De Clercq E; Karlsson A; Kleim JP
    Science; 1997 Jan; 275(5297):229-30; author reply 230-1. PubMed ID: 8999551
    [No Abstract]   [Full Text] [Related]  

  • 18. [Improved long-term success. New nucleoside for once daily combinations].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():31-3. PubMed ID: 15373043
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective expansion of a minor proportion of drug-resistant HIV-1 by antiretroviral pressure in vitro.
    Roberts BD; Pau CP; Weinstock H; Heneine W; Butera ST
    AIDS; 2000 Dec; 14(17):2797-8. PubMed ID: 11125904
    [No Abstract]   [Full Text] [Related]  

  • 20. Lamivudine. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV infection.
    Perry CM; Faulds D
    Drugs; 1997 Apr; 53(4):657-80. PubMed ID: 9098665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.